| Host |
Mouse |
| Klon |
INN-hCG-53 |
| Format |
Lyophilised |
| Methode |
EL, WB |
| Isotyp |
Mouse IgG1 |
HCG (Human Chorionic Gonadotropin)
|
Zytomed Systems GmbH |
INN-hCG-53 |
500 µg |
Lyophilised |
RUO |
608-0014 |
-
|
| Host |
Mouse |
| Klon |
W27 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Breast Carcinoma |
| Verdünnung |
1:25 - 1:100 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm, nucleus |
Heat Shock Protein 70 (HSP70)
|
Diagnostic Biosystems |
W27 |
1 ml |
Concentrate |
CE/IVD |
MOB269 |
-
|
| Host |
Mouse |
| Klon |
W27 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Breast Carcinoma |
| Verdünnung |
1:25 - 1:100 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm, nucleus |
Heat Shock Protein 70 (HSP70)
|
Diagnostic Biosystems |
W27 |
0.1 ml |
Concentrate |
CE/IVD |
MOB269-01 |
-
|
| Host |
Mouse |
| Klon |
W27 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Breast Carcinoma |
| Verdünnung |
1:25 - 1:100 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm, nucleus |
Heat Shock Protein 70 (HSP70)
|
Diagnostic Biosystems |
W27 |
0.5 ml |
Concentrate |
CE/IVD |
MOB269-05 |
-
|
| Host |
Mouse |
| Klon |
W27 |
| Format |
ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Breast Carcinoma |
| Verdünnung |
--- |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cytoplasm, nucleus |
Heat Shock Protein 70 (HSP70)
|
Diagnostic Biosystems |
W27 |
6 ml |
ready-to-use |
CE/IVD |
PDM597 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
EL, WB |
| Isotyp |
Rabbit IgG |
Heat Shock Protein 90a
|
Zytomed Systems GmbH |
polyclonal |
50 µg |
Purified |
RUO |
608-0267 |
-
|
| Host |
Mouse |
| Klon |
DMB15.75 |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
DMB15.75 |
1 ml |
Concentrate |
CE/IVD |
MOB559 |
-
|
| Host |
Mouse |
| Klon |
DMB15.75 |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
DMB15.75 |
0.1 ml |
Concentrate |
CE/IVD |
MOB559-01 |
-
|
| Host |
Mouse |
| Klon |
DMB15.75 |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
DMB15.75 |
0.5 ml |
Concentrate |
CE/IVD |
MOB559-05 |
-
|
| Host |
Rabbit |
| Klon |
Rabbit |
| Format |
Ready-to-use |
| Methode |
P |
| Verdünnung |
- |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
Rabbit |
6 ml |
Ready-to-use |
CE/IVD |
PDR169 |
-
|
| Host |
Rabbit |
| Klon |
Rabbit |
| Format |
Ready-to-use |
| Methode |
P |
| Verdünnung |
- |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
Rabbit |
25 ml |
Ready-to-use |
CE/IVD |
PDR169-25 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP016 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP016-01 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP016-05 |
-
|
| Host |
Rabbit |
| Klon |
Rabbit |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
Rabbit |
1 ml |
Concentrate |
CE/IVD |
RP169 |
-
|
| Host |
Rabbit |
| Klon |
Rabbit |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
Rabbit |
0.1 ml |
Concentrate |
CE/IVD |
RP169-01 |
-
|
| Host |
Rabbit |
| Klon |
Rabbit |
| Format |
Concentrate |
| Methode |
P |
| Lokalisation |
Cytoplasm |
Helicobacter pylori
|
Diagnostic Biosystems |
Rabbit |
0.5 ml |
Concentrate |
CE/IVD |
RP169-05 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
H. pylori infected tissue |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Total lysate of Helicobacter pylori |
| Lokalisation |
Organisms |
Helicobacter pylori
|
Zeta Corporation |
polyclonal |
1ml |
Concentrate |
CE/IVD |
Z2046RL |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
H. pylori infected tissue |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Total lysate of Helicobacter pylori |
| Lokalisation |
Organisms |
Helicobacter pylori
|
Zeta Corporation |
polyclonal |
7 ml |
Ready-to-use |
CE/IVD |
Z2046RP |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
H. pylori infected tissue |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Total lysate of Helicobacter pylori |
| Lokalisation |
Organisms |
Helicobacter pylori
|
Zeta Corporation |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
Z2046RS |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
H. pylori infected tissue |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Total lysate of Helicobacter pylori |
| Lokalisation |
Organisms |
Helicobacter pylori
|
Zeta Corporation |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
Z2046RT |
-
|
| Host |
Mouse |
| Klon |
DBM15.75 |
| Format |
Ready-to-use |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
- |
| Isotyp |
IgG1 |
| Verdünnung |
total lysate of Helicaobacter pylori |
| Lokalisation |
Cytoplasm |
Helicobactor pylori
|
Diagnostic Biosystems |
DBM15.75 |
6 ml |
Ready-to-use |
CE/IVD |
PDM559 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
- |
| Isotyp |
Rabbit Ig |
| Verdünnung |
total lysate of Helicaobacter pylori |
| Lokalisation |
Cytoplasm |
Helicobactor pylori
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR053 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Positivkontrolle |
Infected Stomach or Cells |
| Verdünnung |
- |
| Isotyp |
Rabbit Ig |
| Verdünnung |
total lysate of Helicaobacter pylori |
| Lokalisation |
Cytoplasm |
Helicobactor pylori
|
Diagnostic Biosystems |
polyclonal |
25 ml |
Ready-to-use |
CE/IVD |
PDR053-25 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
F, WB |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Synthetic peptide with the amino acid sequence DLSEALKEATKEVHC corresponding to residues 12-25 (+C-NH2) of human heme oxygenase 1 |
Heme Oxygenase 1 (HO-1, HSP32)
|
Zytomed Systems GmbH |
polyclonal |
50 µg |
Purified |
RUO |
608-0033 |
-
|
| Host |
Rabbit |
| Klon |
SP120 |
| Format |
Concentrate |
| Reaktivität |
RB, RT |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Pancreas, Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Synthetic peptide derived from the internal region of human hENT1 protein. |
| Lokalisation |
Cell Membrane |
hENT1
|
Zytomed Systems GmbH |
SP120 |
0.5 ml |
Concentrate |
RUO |
508-4202 |
-
|
| Host |
Rabbit |
| Klon |
SP120 |
| Format |
Concentrate |
| Reaktivität |
RB, RT |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Pancreas, Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Synthetic peptide derived from the internal region of human hENT1 protein. |
| Lokalisation |
Cell Membrane |
hENT1
|
Zytomed Systems GmbH |
SP120 |
1 ml |
Concentrate |
RUO |
508-4204 |
-
|
| Host |
Mouse |
| Klon |
T320.11 |
| Format |
Purified |
| Methode |
EL, WB |
| Isotyp |
Mouse IgG1 |
Heparan Sulfate
|
Zytomed Systems GmbH |
T320.11 |
100 µg |
Purified |
RUO |
608-0036 |
-
|
| Host |
Mouse |
| Format |
Purified |
| Methode |
P, WB |
| Verdünnung |
1:40 (P) |
| Isotyp |
Mouse IgG2b |
| Verdünnung |
Polypeptide from the 50 kDa subunit of heparanase |
Heparanase 1 (Hep1)
|
Zytomed Systems GmbH |
- |
100 µg |
Purified |
RUO |
608-0040 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
F, P, EL |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Hepatitis B subtypes ad and ay |
Hepatitis B Surface Antigen (HBsAg)
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Purified |
RUO |
608-0073 |
-
|
| Host |
Mouse |
| Klon |
5C3 |
| Format |
Concentrate |
| Methode |
P |
| Isotyp |
Mouse IgG |
| Lokalisation |
Cytoplasm |
Hepatitis B Surface Antigen (HBsAg)
|
Diagnostic Biosystems |
5C3 |
0.1 ml |
Concentrate |
RUO |
MOB570-01R |
-
|
| Host |
Mouse |
| Klon |
5C3 |
| Format |
Concentrate |
| Methode |
P |
| Isotyp |
Mouse IgG |
| Lokalisation |
Cytoplasm |
Hepatitis B Surface Antigen (HBsAg)
|
Diagnostic Biosystems |
5C3 |
0.5 ml |
Concentrate |
RUO |
MOB570-05R |
-
|
| Host |
Mouse |
| Klon |
5C3 |
| Format |
Concentrate |
| Methode |
P |
| Isotyp |
Mouse IgG |
| Lokalisation |
Cytoplasm |
Hepatitis B Surface Antigen (HBsAg)
|
Diagnostic Biosystems |
5C3 |
1 ml |
Concentrate |
RUO |
MOB570R |
-
|
| Host |
Mouse |
| Klon |
5C3 |
| Format |
Ready-to-use |
| Methode |
P |
| Verdünnung |
- |
| Isotyp |
Mouse IgG |
| Lokalisation |
Cytoplasm |
Hepatitis B Surface Antigen (HBsAg)
|
Diagnostic Biosystems |
5C3 |
6 ml |
Ready-to-use |
RUO |
PDM570R |
-
|
| Host |
Mouse |
| Klon |
3F6-G10 |
| Format |
Purified |
| Methode |
F, P, EL |
| Positivkontrolle |
Liver Carcinoma or Hepatitis B infected liver |
| Verdünnung |
1:100 (P) |
| Isotyp |
Mouse IgG2a |
| Verdünnung |
HB-Xag-Protein A Fusion protein |
Hepatitis Bx Antigen (HBxAg)
|
Zytomed Systems GmbH |
3F6-G10 |
250 µg |
Purified |
RUO |
608-0079 |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Liver |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Hepatocyte (HepPar1)
|
Diagnostic Biosystems |
OCH1E5 |
1 ml |
Concentrate |
CE/IVD |
MOB426 |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Liver |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Hepatocyte (HepPar1)
|
Diagnostic Biosystems |
OCH1E5 |
0.1 ml |
Concentrate |
CE/IVD |
MOB426-01 |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Liver |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Hepatocyte (HepPar1)
|
Diagnostic Biosystems |
OCH1E5 |
0.5 ml |
Concentrate |
CE/IVD |
MOB426-05 |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Positivkontrolle |
Liver |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Hepatocyte (HepPar1)
|
Diagnostic Biosystems |
OCH1E5 |
6 ml |
Ready-to-use |
CE/IVD |
PDM162 |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Hepatocellular carcinoma. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Formalin fixed failed human allograft liver that was mechanically disrupted actual price paid for the product |
| Lokalisation |
Cytoplasm |
HepPar-1
|
Zeta Corporation |
OCH1E5 |
1.0 ml |
Concentrate |
CE/IVD |
Z2087ML |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Hepatocellular carcinoma. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Formalin fixed failed human allograft liver that was mechanically disrupted actual price paid for the product |
| Lokalisation |
Cytoplasm |
HepPar-1
|
Zeta Corporation |
OCH1E5 |
7 ml |
Ready-to-use |
CE/IVD |
Z2087MP |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Hepatocellular carcinoma. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Formalin fixed failed human allograft liver that was mechanically disrupted actual price paid for the product |
| Lokalisation |
Cytoplasm |
HepPar-1
|
Zeta Corporation |
OCH1E5 |
0.5 ml |
Concentrate |
CE/IVD |
Z2087MS |
-
|
| Host |
Mouse |
| Klon |
OCH1E5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Hepatocellular carcinoma. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Formalin fixed failed human allograft liver that was mechanically disrupted actual price paid for the product |
| Lokalisation |
Cytoplasm |
HepPar-1
|
Zeta Corporation |
OCH1E5 |
0.1 ml |
Concentrate |
CE/IVD |
Z2087MT |
-
|
| Host |
Rabbit |
| Klon |
ZR5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Breast carcinomas. |
| Verdünnung |
1:200 - 1:300 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant protein encoding extracellular domain of human c-erbB2 |
| Lokalisation |
Cell membrane |
Her-2-/neu
|
Zeta Corporation |
ZR5 |
1.0 ml |
Concentrate |
RUO |
Z2025RL-R |
-
|
| Host |
Rabbit |
| Klon |
ZR5 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Breast carcinomas. |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Recombinant protein encoding extracellular domain of human c-erbB2 |
| Lokalisation |
Cell membrane |
Her-2-/neu
|
Zeta Corporation |
ZR5 |
7 ml |
Ready-to-use |
RUO |
Z2025RP-R |
-
|
| Host |
Rabbit |
| Klon |
ZR5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Breast carcinomas. |
| Verdünnung |
1:200 - 1:300 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant protein encoding extracellular domain of human c-erbB2 |
| Lokalisation |
Cell membrane |
Her-2-/neu
|
Zeta Corporation |
ZR5 |
0.5 ml |
Concentrate |
RUO |
Z2025RS-R |
-
|
| Host |
Rabbit |
| Klon |
ZR5 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Breast carcinomas. |
| Verdünnung |
1:200 - 1:300 |
| Isotyp |
IgG |
| Verdünnung |
Recombinant protein encoding extracellular domain of human c-erbB2 |
| Lokalisation |
Cell membrane |
Her-2-/neu
|
Zeta Corporation |
ZR5 |
0.1 ml |
Concentrate |
RUO |
Z2025RT-R |
-
|
| Host |
Rabbit |
| Klon |
EP3 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Diva modified Citrate pH 6.2 |
| Positivkontrolle |
Breast carcinoma |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell membrane |
HER2 (c-erbB-2)
|
Biocare Medical |
EP3 |
0.1 ml |
Concentrate |
RUO |
CME342A |
-
|
| Host |
Rabbit |
| Klon |
EP3 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Diva modified Citrate pH 6.2 |
| Positivkontrolle |
Breast carcinoma |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell membrane |
HER2 (c-erbB-2)
|
Biocare Medical |
EP3 |
0.5 ml |
Concentrate |
RUO |
CME342B |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrat |
| Positivkontrolle |
Breast Carcinoma |
| Verdünnung |
- |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell Membrane |
HER2 (c-erbB-2)
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR003 |
-
|